title: Early discharge after appendicectomy in children.
abstract: OBJECTIVE
  To confirm that "day-care" appendicectomy is safe in children.
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  Paediatric hospitals, Brazil.
  
  
  METHODS
  144 children who required removal of the appendix.
  
  
  METHODS
  Standard muscle splitting appendicectomy.
  
  
  METHODS
  Hospital stay, use of antibiotics, and complications.
  
  
  RESULTS
  124 patients (86%) were discharged within 24 hours of operation. In all patients the appendicitis was confirmed and grouped according to histopathological findings (72 inflamed, 26 gangrenous and 26 perforated). 86 patients (60%) were given metronidazole one hour before operation as prophylaxis against postoperative abscess formation. 78 (54%) were given no antibiotics in the postoperative period. 2 patients were readmitted for drainage of intraperitoneal abscesses and 10 had subcutaneous abscesses drained as outpatients during the early postoperative period. The overall infective complication rate was 8% (n = 12), which is comparable with large series of appendicectomy in children.
  
  
  CONCLUSIONS
  "Day-care" appendicectomy is safe and feasible in children, as it avoids a long hospital stay and increased costs with no additional risk.
authors.affiliation: Division of Pediatric Surgery, Children's Institute, Hospital da Santa Casa de Ribeirão Preto, São Paulo, Brazil.
authors.forename: C E
authors.initials: CE
authors.lastname: Velhote
authors.forename: T F
authors.initials: TF
authors.lastname: de Oliveira Velhote
authors.forename: M C
authors.initials: MC
authors.lastname: Velhote
authors.forename: D C
authors.initials: DC
authors.lastname: Moura
mesh_terms: D000293:Adolescent; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001062:Appendectomy; D001938:Brazil; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007902:Length of Stay; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D010351:Patient Discharge; D011183:Postoperative Complications / Q000517:prevention & control; D011446:Prospective Studies
chemical_list: D000890:Anti-Infective Agents; D008795:Metronidazole